Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma

Biomedical Research (Japan)

Volumn 34, Issue 1, 2013, Pages 13-21

  Goudarzi, Houman ^a   Hida, Yasuhiro ^b   Takano, Hiroko ^b   Teramae, Hiroki ^c   Iizasa, Hisashi ^a   Hamada, Jun Ichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHUMEI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 5; CYTOKERATIN 6; HYALURONIC ACID; MESOTHELIN; PODOPLANIN; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1; WT1 PROTEIN;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL DENSITY; CELL GROWTH; CELL HYPOXIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PLEURA EFFUSION; PLEURA MESOTHELIOMA; TUMOR CELL;

CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL HYPOXIA; CELL LINE, TUMOR; GPI-LINKED PROTEINS; HUMANS; HYALURONIC ACID; KERATIN-5; MALE; MEMBRANE GLYCOPROTEINS; MESOTHELIOMA; MIDDLE AGED; NUCLEAR PROTEINS; PLEURAL EFFUSION; PLEURAL NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874297791     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.34.13     Document Type: Article

References (32)

1. Aoe K, Hiraki A, Murakami T, Toyooka S, Shivapurkar N, Gazdar AF, Sueoka N, Taguchi K, Kamei T, Takeyama H, Sugi K and Kishimoto T (2006) Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan. Cancer Sci 97, 292-295.
2. Bar EE, Lin A, Mahairaki V, Matsui W and Eberhart CG (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177, 1491-1502.
3. Brown JM (1999) The hypoxic cell: a target for selective cancer therapy-Eighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 59, 5863-5870.
4. Gazdar AF and Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5, 177-181.
5. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91.
6. Graziani I, Eliasz S, De Marco MA, Chen Y, Pass HI, De May RM, Strack PR, Miele L and Bocchetta M (2008) Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res 68, 9678-9685.
7. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38-47.
8. Ho L, Sugarbaker DJ and Skarin AT (2001) Malignant pleural mesothelioma. Cancer Treat Res 105, 327-373.
9. Horai T, Imamura F, Nakae T, Nakamura S, Mukai M, Shinkai K, Higashino K and Akedo H (1992) Interactions of lung cancer cells with the human mesothelial cell monolayer: An in vitro model for cancer invasion. Jpn J Clin Oncol 22, 67-72.
10. Huang H, Reis R, Yonekawa Y, Lopes JM, Kleihues P and Ohgaki H (1999) Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 9, 33-42.
11. Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson A, Roggli V, Travis WD and Wick M (2012) Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 Update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med, in press (doi: 10.5858/arpa.2012-0214-OA)
12. Kamp DW (2009) Asbestos-induced lung diseases: an update. Transl Res 153, 143-152.
13. Kitamura F, Araki S, Suzuki Y, Yokoyama K, Tanigawa T and Iwasaki R (2002) Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients. Ind Health 40, 175-181.
14. Klabatsa A, Sheaff MT, Steele JP, Evans MT, Rudd RM and Fennell DA (2006) Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM). Lung Cancer 51, 53-59.
15. Kobayashi M, Takeuchi T and Ohtsuki Y (2008) Establishment of three novel human malignant pleural mesothelioma cell lines: Morphological and cytogenetical studies and EGFR mutation status. Anticancer Res 28, 194-208.
16. Lee AY, Raz DJ, He B and Jablons DM (2007) Update on the molecular biology of malignant mesothelioma. Cancer 109, 1454-1461.
17. Li Y and Heldin P (2001) Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 85, 600-607.
18. López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB and Ladanyi M (2006) Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 66, 2970-2979.
19. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM and Suo Z (2011) Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS One 6, e29170.
20. Macheda ML, Rogers S and Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202, 654-662.
21. Magee JA, Piskounova E and Morrison SJ (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283-296.
22. Mor O, Yaron P, Huszar M, Yellin A, Jakobovitz O, Brok-Simoni F, Rechavi G and Reichert N (1997) Absence of p53 mutations in malignant mesotheliomas. Am J Respir Cell Mol Biol 16, 9-13.
23. Murayama T, Takahashi K, Natori Y and Kurumatani N (2006) Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 49, 1-7.
24. Nakataki E, Yano S, Matsumori Y, Goto H, Kakiuchi S, Muguruma H, Bando Y, Uehara H, Hamada H, Kito K, Yokoyama A and Sone S (2006) Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor. Cancer Sci 97, 183-191.
25. Nasreen N, Mohammed KA, Ward MJ and Antony VB (1999) Mycobacterium-induced transmesothelial migration of monocytes into pleural space: role of intercellular adhesion molecule- 1 in tuberculous pleurisy. J Infect Dis 180, 1616-1623.
26. Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35, 71-103.
27. Vaupel P, Mayer A and Hockel M (2004) Tumor hypoxia and malignant progression. Methods Enzymol 381, 335-354.
28. Vaupel P and Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26, 225-239.
29. Warburg O (1956) On the origin of cancer cells. Science 123, 309-314.
30. Yanagihara K, Tsumuraya M, Takigahira M, Mihara K, Kubo T, Ohuchi K and Seyama T (2010) An orthotopic implantation mouse model of human malignant pleural mesothelioma for in vivo photon counting analysis and evaluation of the effect of S-1 therapy. Int J Cancer 126, 2835-2846.
31. Yeung TM, Gandhi SC and Bodmer WF (2011) Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 108, 4382-4387.
32. Yoshikawa K, Hamada J, Tada M, Kameyama T, Nakagawa K, Suzuki Y, Ikawa M, Hassan NM, Kitagawa Y and Moriuchi T (2010) Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells. Biomed Res 31, 401-411.